Source: PR Newswire

Press Release: Calliditas Therapeutics AB : Calliditas Moves its Annual General Meeting 2020 to June 25

/PRNewswire/ -- Calliditas Therapeutics AB (publ) ("Calliditas") today announced that due to the recent Covid-19 pandemic, the Company has decided to move its...

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Employees
Renee Aguiar-Lucander's photo - CEO of Calliditas

CEO

Renee Aguiar-Lucander

CEO Approval Rating

90/100

Calliditas is a pharmaceutical company that develops and commercializes therapeutics for the treatment of inflammatory kidney diseases. Read more